Introduction
hospitals appears to be worse [5 ] , even though they presumably see more serious reactions. However, there are no published data that confirm the degree of There is a high level of under-reporting of suspected adverse drug reactions (ADRs) to the Yellow Card under-reporting from hospitals in the UK. From 1988 to 1995 we ran a local ADR reporting Scheme of the Committee on Safety of Medicines (CSM) in the UK [1, 2] , and according to the 1993/94 annual scheme to investigate patients being treated on the general medical unit of the John Radcliffe Hospital. report of the Medicines Control Agency (MCA) [3 ] this appears to be getting worse, since the number of This research project was established in order to monitor and assess suspected ADRs, to highlight local prescribing yellow cards sent by doctors during the year dealt with by the report had fallen by 17%. It has been suggested problems, and to give feedback to doctors, nurses, and pharmacists. that at most only 14% of all suspected ADRs are reported in General Practice [4 ] , and reporting from As part of our general analysis of suspected ADRs
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reported to the Oxford Scheme, we retrospectively drug reaction was classified as dose-related, nondose-related, long-term, or unknown, using published determined the numbers and types of reactions that would have merited notification as yellow card reports evidence to make the classification. Data were stored in the form of records relating to according to the guidelines of the CSM, and have compared them with the suspected adverse reactions reactions and reports in a database developed in 'dbase'. It is important to recognise the difference between for which yellow cards were known to have been sent. We present here data collected over 3 years relating to records, reactions, and reports in this system. For example, a rash that could have been caused by either 20 695 consecutive acute general medical admissions.
of two co-administered antibiotics, amoxycillin or flucloxacillin, would be represented by two records, one for each drug, but by only one reaction and one report. However, should two different reactions occur at the Methods same time they would be classified as two reactions but only one report. The Oxford Adverse Drug Reactions Scheme operated on seven acute general medical wards (140 beds) in the The CSM requests in the BNF that the following types of reactions be reported on yellow cards: John Radcliffe Hospital, including one specialist gastroenterology ward. The scheme was run by a part-time 'NEWER DRUGS. These are indicated by the sign ,. Doctors are asked to report all suspected reactions research pharmacist. Any health-care professional could initiate a report on a suspected ADR, either by writing (i.e. any adverse or any unexpected event, however minor, which could conceivably be attributed to the the suspected drug, the adverse event, and the reporter's name on a form kept at the end of each bed, or by drug). Reports should be made despite uncertainty about a causal relationship, irrespective of whether contacting the ADR research pharmacist, who visited the wards regularly and investigated and evaluated the the reaction is well recognized, and even if other drugs have been given concurrently.' reports. Deliberate overdoses were excluded. When a rare or unusual reaction occurred, doctors were asked 'ESTABLISHED DRUGS. Doctors are asked to report all serious suspected reactions, including those to sign a yellow card which had been completed in detail by the ADR research pharmacist. These methods that are fatal, life-threatening, disabling, incapacitating, or which result in or prolong hospitalisation; they have previously been reported [6, 7 ] .
The reactions were classified by their occurrence should be reported even if the effect is well recognised.' Using these criteria for this study, we have flagged the before or during the current hospital admission. Reactions that occurred before the admission were following reactions on our database that would have merited a yellow card: further classified according to whether they caused the admission or were coincidental. All reactions were $ Any suspected adverse reaction attributed to a black triangle drug. given a severity score (Table 1 ) and causality was assessed subjectively by the same experienced pharma-$ Any suspected adverse reaction, attributed to an established drug, that caused the hospital admission cist, with help when necessary from a clinical pharmacologist. The suspected drugs were categorized (severity scores 3, 4, or 5). $ Any suspected adverse reaction, attributed to an according to the BNF and to whether they were black triangle drugs or not. The suspected reaction was established drug, that was serious and occurred during an in-patient stay (severity scores 4 or 5). coded according to the 1990 CSM's computerized database of adverse events. The mechanism of each We asked the CSM for information on the number of In all, 477 potential yellow cards were retrospectively identified (123 in 1990/1, 203 in 1991/2, and 151 in Scheme and 1420 reports of suspected ADRs. This is equivalent to 68.7 reports per 1000 admissions (Table 2) 1992/3), but only 30 (6.3%) were known to have been sent. Details of these 30 yellow cards are shown in or about 1 report per 15 admissions. One-third were present on admission and two-thirds occurred after Table 3 . Data provided by the CSM suggested that the scheme was responsible for almost all of the yellow admission. Only 2.3% of all reports involved a black triangle drug.
cards received from the medical unit of the John Radcliffe Hospital, and the overall reporting for the hospital was similar to or better than other teaching hospitals. However, the CSM has emphasized that this Suspected reactions meriting yellow cards information may be incomplete. If the CSM's guidelines for reporting had been strictly followed, 477 reports on the scheme would have been identified as meriting yellow cards. The reporting rate T ypes of ADRs detected for yellow cards would have been 23.1 per 1000 admissions ( gastrointestinal haemorrhage, toxicity from drugs with Drug interactions causing ADRs a low therapeutic index (e.g. warfarin, digoxin), and impaired renal function (e.g. due to diuretics, ACE Drug interactions caused ADRs in only 31 of the 1420 reports (1.50 per 1000 admissions). Twenty-two were inhibitors). Gastrointestinal haemorrhage was the most frequent (15% of potential yellow cards); aspirin, serious enough to merit a potential yellow card (1.06 per 1000 admissions) and three were known to have responsible for 27% of these records, was the single drug most often implicated, and the non-aspirin nonbeen been reported as yellow cards (0.14 per 1000 admissions). None of these interactions was novel and steroidal anti-inflammatory drugs (NSAIDs) were responsible for 50%. We have reported elsewhere the all involved drugs with a low therapeutic index; warfarin, the most frequent, was implicated in 19 of the 31 reports, data on individual NSAIDs [8 ].
14 of the 22 potential yellow cards, and all three actual yellow cards. The other drugs with a low therapeutic index implicated in the interactions were aminophylMechanism of event line, carbamazepine, cyclosporin, digoxin, lithium, and phenytoin. Most of the reactions reported to the scheme were doserelated (Table 4 ) , accounting for 80.3% of all records. This pattern was also observed with potential yellow cards (72.3% of records). This is in contrast to the Groups detecting ADRs pattern seen among yellow cards that were known to have been sent to the CSM, where the numbers of dose-
The two main groups of health-care professionals who detected suspected ADRs on the Oxford scheme related and non-dose-related reactions were similar. In a parallel study in the John Radcliffe Hospital (HMP, unpublished observations), 1071 acute medical detected 240 reactions meriting a potential yellow card (50.4%), of which the ADR research pharmacist was admissions were systematically reviewed in search of ADRs recorded in the medical notes. In all, 36 significant responsible for 144 reactions; nurses detected 189 (39.6%) and doctors detected 48 (10.1%). Of the 30 reactions resulting in admission were identified (33.6 reports per 1000 admissions), including one reaction yellow cards known to have been sent, 15 (50%) were initiated by pharmacists, 9 (30%) by doctors, and 6 attributed to a black triangle drug. A review of 871 of these patients identified four serious reactions that (20%) by nurses. occurred during their in-patient stay (4.6 reports per the actual yellow cards known to have been sent, only 41.7% were for dose-related reactions. 1000 admissions). This gives an overall rate of 38.2 potential yellow card reports per 1000 admissions, There were few reported reactions to black triangle drugs (31 reports). This probably reflected the low usage compared with a rate of 23.1 reports per 1000 admissions reported to the Oxford Scheme. Thus, the estimated of these drugs in Oxford at the time of the study, although it may be that the newer drugs were safer. efficacy of the Oxford Scheme to detect reactions meriting a yellow card is 60.3%.
Although there are many documented drug interactions, our data suggest that they do not often cause adverse drug reactions. Only 31 suspected adverse interactions were reported to the scheme, but 22 were serious enough to merit a potential yellow card, all involving drugs with a low therapeutic index. Over a period of 1 month yellow cards were sent for three patients admitted to hospital with haemorrhage and an Discussion INR greater than 15 as a result of the interaction between azapropazone and warfarin. These cases The Yellow Card Scheme of the CSM is vital for the identification of previously unknown ADRs, for example prompted joint letters from us and the local FHSA medical adviser to all local GPs and Community blood dyscrasias with mianserin [9 ] , the hepatotoxicity of amiodarone [10 ] , and cardiac arrhythmias with Pharmacists, warning them of this contraindication, and an educational presentation was made at a medical terodiline [11 ] . The data are also used to assess the risk5benefit profile of both new and established drugs.
grand round. Although nurses made 702 reports to the scheme, The CSM asks for ADR reports of two types: all reactions to black triangle drugs and serious reactions only 189 (27%) were serious enough to merit a potential yellow card. Pharmacists made slightly fewer reports to to established drugs. Recognising the difficulties in categorizing serious ADRs, the Committee has issued the scheme, 635, but 240 of these (38%) were serious enough to merit a potential yellow card. Although guidance on which ADRs to report [12 ] . For the purposes of this study we designated as serious those doctors were responsible for only 48 of the potential yellow cards, these represented 58% of their reports to reactions that caused admission to hospital or were potentially life-threatening reactions occurring in hospithe scheme, indicating the more serious nature of their reports. tal. Certainly not every case of, for example, 'hypokalaemia', 'renal dysfunction', or 'hypotension' was a serious
The number of yellow cards submitted by our scheme is comparable with other schemes. The Green Card reaction.
The CSM emphasizes that for yellow card reporting Scheme in Liverpool [ 16] resulted in 176 yellow cards from about 28 000 admissions per year over 3 years proven causality is not essential. Validation of ADRs is contentious, and even standardized assessment methods, (2.1 per 1000 admissions); these cards originated from specialties throughout the hospital. In Oxford 30 such as algorithms and decision tables, produce disagreement amongst experts, particularly in attributing cause completed cards resulted over 3 years from about 7000 admissions per year on the medical wards alone (1.5 to the drug rather than other factors [13 ] . Subjective validation by experienced pharmacists and clinicians, as per 1000 admissions). In a pilot study in the former Northern Region [17 ] , in which hospital pharmacists we have used, is therefore still used by many workers [ 14] . signed yellow cards with the doctor's approval, 145 yellow cards were sent during the first year by 47 Using the Oxford Scheme we have analysed 1420 spontaneous reports of ADRs derived from 20 695 pharmacists in 13 of the Region's 15 Districts. In the second year 142 yellow cards were sent [Northern medical admissions over a 3-year period. Using the guidelines produced by the CSM, we have retrospectively Regional Drug and Therapeutics Centre, personal communication]. However, no data were readily availidentified 477 reactions that merited a potential yellow card (23.1 per 1000 admissions). Of these potential able to correlate the number of yellow card reports with the number of admissions in this study. yellow cards, 357 (74.8%) were reactions causing admission to hospital. The total number of drug-related admissions found in the present study (2.3%) is similar to that found in other studies [15 ] . Only 129 potential yellow cards (25.2%) were for reactions that occurred
Under-reporting to the Oxford Scheme in hospital; 99 of these were serious reactions to established drugs and 21 were reactions to black triangle
We have estimated that the overall efficacy of the Oxford Scheme for detecting potential yellow cards was drugs, of which only 6 were serious.
Most of the reactions in the reports identified as 60%. The scheme appeared to detect serious reactions that occurred during the in-patient stay and most of the potential yellow cards were dose-related (72.3% of records). Many of these were well-known reactions reports implicated a black triangle drug. However, only about half of the significant reactions resulting in resulting from either the primary or secondary pharmacological action of the drug, such as gastrointestinal admission were reported to the scheme, which may reflect a greater emphasis by clinical staff on reporting haemorrhage, toxicity from drugs with a low therapeutic index, and impairment of renal function. However, of events that occurred in hospital.
